Global Pain Management Therapeutics Market Review 2016-2018 & Forecast 2019-2024 – ResearchAndMarkets.com

August 30, 2019 Off By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Pain Management Therapeutics Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s offering.

The report predicts the global pain management therapeutics market to grow with a CAGR of 4.5% over the forecast period from 2018-2024.

The report on the global pain management therapeutics market provides qualitative and quantitative analysis for the period from 2016 to 2024. The study on pain management therapeutics market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2016 to 2024.

The report on pain management therapeutics market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global pain management therapeutics market over the period of 2016 to 2024. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter’s five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global pain management therapeutics market over the period of 2016 to 2024. Further, the growth matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1. Drivers

  • The growing number of people suffering from chronic disease
  • Increase incidence of accidental and sports injuries
  • Growing geriatric population

2. Restraints

  • Low adoption in the emerging market

3. Opportunities

  • Ongoing research and development in pain therapeutics

Key Topics Covered

1. Preface

1.1. Report Description

1.2. Research Methods

1.3. Research Approaches

2. Executive Summary

2.1. Pain Management Therapeutics Market Highlights

2.2. Pain Management Therapeutics Market Projection

2.3. Pain Management Therapeutics Market Regional Highlights

3. Global Pain Management Therapeutics Market Overview

3.1. Introduction

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. Porter’s Five Forces Analysis

3.4. Growth Matrix Analysis

3.4.1. Growth Matrix Analysis by Indication

3.4.2. Growth Matrix Analysis by Therapeutics

3.4.3. Growth Matrix Analysis by Distribution Channel

3.4.4. Growth Matrix Analysis by Region

3.5. Value Chain Analysis of Pain Management Therapeutics Market

4. Pain Management Therapeutics Market Macro Indicator Analysis

5. Global Pain Management Therapeutics Market by Indication

5.1. Chronic Back Pain

5.2. Neuropathic Pain

5.3. Fibromyalgia

5.4. Arthritic Pain

5.5. Cancer Pain

5.6. Post-Operative Pain

5.7. Migraine

5.8. Others

6. Global Pain Management Therapeutics Market by Therapeutics

6.1. Anesthetics

6.2. Antidepressants

6.3. Anticonvulsants

6.4. Non-steroidal Anti-inflammatory Drugs (NSAIDS)

6.5. Anti-migraine Agents

6.6. Opioids

6.7. Non-narcotic Analgesics

6.8. Others

7. Global Pain Management Therapeutics Market by Distribution Channel

7.1. Online Pharmacy

7.2. Hospitals Pharmacy

7.3. Retail Pharmacy

8. Global Pain Management Therapeutics Market by Region 2018-2024

8.1. North America

8.1.1. North America Pain Management Therapeutics Market by Indication

8.1.2. North America Pain Management Therapeutics Market by Therapeutics

8.1.3. North America Pain Management Therapeutics Market by Distribution Channel

8.1.4. North America Pain Management Therapeutics Market by Country

8.2. Europe

8.3. Asia-Pacific

8.4. RoW

9. Company Profiles and Competitive Landscape

9.1. Competitive Landscape in the Global Pain Management Therapeutics Market

9.2. Companies Profiles

9.2.1. Abbott

9.2.2. Eli Lilly & Company

9.2.3. Pfizer Inc.

9.2.4. Johnson & Johnson Services

9.2.5. Novartis AG

9.2.6. Merck & Co. Inc.

9.2.7. AstraZeneca

9.2.8. Endo Pharmaceuticals Inc.

9.2.9. Teva Pharmaceutical Industries Ltd.

9.2.10. Mallinckrodt Pharmaceuticals Company

For more information about this report visit https://www.researchandmarkets.com/r/19r566

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900